199 related articles for article (PubMed ID: 11402025)
41. Engineering of α1-antitrypsin variants with improved specificity for the proprotein convertase furin using site-directed random mutagenesis.
Hada K; Isshiki K; Matsuda S; Yuasa K; Tsuji A
Protein Eng Des Sel; 2013 Feb; 26(2):123-31. PubMed ID: 23155057
[TBL] [Abstract][Full Text] [Related]
42. Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor-I in a rat clonal dental pulp-cell line.
Kawase T; Orikasa M; Ogata S; Burns DM
Arch Oral Biol; 1995 Oct; 40(10):921-9. PubMed ID: 8526802
[TBL] [Abstract][Full Text] [Related]
43. Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells.
Plymate SR; Bae VL; Maddison L; Quinn LS; Ware JL
Endocrinology; 1997 Apr; 138(4):1728-35. PubMed ID: 9075737
[TBL] [Abstract][Full Text] [Related]
44. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
45. Insulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase Activation.
Law NC; Hunzicker-Dunn ME
J Biol Chem; 2016 Feb; 291(9):4547-60. PubMed ID: 26702053
[TBL] [Abstract][Full Text] [Related]
46. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers.
Szepeshazi K; Schally AV; Groot K; Armatis P; Halmos G; Herbert F; Szende B; Varga JL; Zarandi M
Br J Cancer; 2000 May; 82(10):1724-31. PubMed ID: 10817510
[TBL] [Abstract][Full Text] [Related]
47. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G
Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282
[TBL] [Abstract][Full Text] [Related]
48. Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models.
Park JY; Murakami T; Lee JY; Zhang Y; Hoffman RM; Bouvet M
PLoS One; 2016; 11(1):e0146504. PubMed ID: 26731105
[TBL] [Abstract][Full Text] [Related]
49. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
Jenkins PJ; Khalaf S; Ogunkolade W; McCarthy K; David T; Hands RE; Davies D; Bustin SA
Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329
[TBL] [Abstract][Full Text] [Related]
50. Effect of receptor phosphorylation on the binding between IRS-1 and IGF-1R as revealed by surface plasmon resonance biosensor.
Huang M; Lai WP; Wong MS; Yang M
FEBS Lett; 2001 Sep; 505(1):31-6. PubMed ID: 11557037
[TBL] [Abstract][Full Text] [Related]
51. Insulin-like growth factor-mediated phosphorylation and protooncogene induction in Madin-Darby canine kidney cells.
Hauguel-de Mouzon S; Kahn CR
Mol Endocrinol; 1991 Jan; 5(1):51-60. PubMed ID: 1708099
[TBL] [Abstract][Full Text] [Related]
52. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
53. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
54. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Bassi DE; Mahloogi H; Klein-Szanto AJ
Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
[TBL] [Abstract][Full Text] [Related]
55. Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury.
Niu XL; Li J; Hakim ZS; Rojas M; Runge MS; Madamanchi NR
J Biol Chem; 2007 Jul; 282(27):19808-19. PubMed ID: 17500057
[TBL] [Abstract][Full Text] [Related]
56. Insulin-like growth factors induce apoptosis as well as proliferation in LIM 1215 colon cancer cells.
Fu P; Thompson JA; Leeding KS; Bach LA
J Cell Biochem; 2007 Jan; 100(1):58-68. PubMed ID: 16888814
[TBL] [Abstract][Full Text] [Related]
57. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
[TBL] [Abstract][Full Text] [Related]
58. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme.
Dubois CM; Blanchette F; Laprise MH; Leduc R; Grondin F; Seidah NG
Am J Pathol; 2001 Jan; 158(1):305-16. PubMed ID: 11141505
[TBL] [Abstract][Full Text] [Related]
59. Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells.
Wang H; Iezzi M; Theander S; Antinozzi PA; Gauthier BR; Halban PA; Wollheim CB
Diabetologia; 2005 Apr; 48(4):720-31. PubMed ID: 15756539
[TBL] [Abstract][Full Text] [Related]
60. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action.
Fulzele K; DiGirolamo DJ; Liu Z; Xu J; Messina JL; Clemens TL
J Biol Chem; 2007 Aug; 282(35):25649-58. PubMed ID: 17553792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]